Bifocal Lenses In Nearsighted Kids

Not Applicable

Completed

Conditions: Refractive Errors

Interventions: Device: Biofinity Multifocal D +1.50 add
Device: Biofinity
Device: Biofinity Multifocal D +2.50 add

Registration Number: NCT02255474

Lead Sponsor: Ohio State University

Brief Summary: This study will evaluate the use of two different bifocal contact lens add powers to prevent further nearsighted progression in children ages 7 to 11 years old. It is theorized that the profile of the bifocal lenses will decrease the amount of change in nearsightedness that the children experience.

Detailed Description: The primary goal of this project is to determine whether a commercially available soft bifocal contact lens with a distance-center design can slow myopia progression in children. Using soft bifocal contact lenses to manipulate the peripheral optics of the eye is a novel use for a standard contact lens that may keep children from becoming as nearsighted as they would otherwise. Secondary goals are to determine whether the amount of myopic defocus imposed on the peripheral retina by soft bifocal contact lenses is associated in a dose-dependent manner with slowed myopic progression and to determine whether peripheral myopic blur acts to slow eye growth locally or globally. These important pieces of information will enable investigators to learn about the role of peripheral optics for regulating eye growth, which could ultimately lead to optimization of optical signals to slow myopia progression. Ultimately, the information could be used to design optical devices to prevent the onset of myopia in young children.

Slowing myopia progression or eventually preventing myopia onset could potentially affect approximately 60 million children in the United States alone. While the consequences of myopia are rarely sight-threatening, the quality of life for myopic patients is negatively affected and the health care costs to treat myopia are astronomical (approximately $4.6 billion in 1990). The National Eye Institute recognizes the need to "evaluate the efficacy of potential treatments for delaying the onset or for slowing the progression of myopia, such as lenses that alter peripheral defocus."

Using a common treatment of myopia (contact lenses) to potentially slow myopia progression and to learn about optical signals that regulate eye growth is a very novel approach to solving a problem that affects a large proportion of people in the United States.

Recruitment & Eligibility

Status: COMPLETED

Sex: All

Target Recruitment: 294

Inclusion Criteria

7 to 11 years, inclusive, at baseline examination
-0.75 to -5.00 D, inclusive, spherical component, cycloplegic autorefraction
≤1.00 DC, cycloplegic autorefraction
≥ 2.00 D difference between the sphere components of the two eyes (anisometropia), cycloplegic autorefraction
0.1 logMAR or better best-corrected visual acuity in each eye
0.1 logMAR or better visual acuity OU distance and near with a +2.50 D add contact lens
+2.50 D add lens provides adequate fit with respect to movement and centration

Exclusion Criteria

Eye disease or binocular vision problems (e.g., strabismus, amblyopia, oculomotor nerve palsies, corneal disease, etc.)
Systemic disease that may affect vision, vision development, or contact lens wear (eg, diabetes, Down syndrome, etc.)
Previous gas permeable, soft bifocal, or orthokeratology contact lens wear or bifocal/PAL spectacle wear (longer than 1 month of wear)
Previous or current participation in myopia control studies
Chronic use of medications that may affect immunity, such as oral or ophthalmic corticosteroids for ocular or systemic diseases
Issues that may interfere with the ability to participate over the next 3 years

Study & Design

Study Type: INTERVENTIONAL

Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Biofinity Multifocal D +1.50 add	Biofinity Multifocal D +1.50 add	The Biofinity Multifocal "D" with a +1.50 add is a soft bifocal contact lens that has a medium reading power
Biofinity	Biofinity	Soft spherical contact lens
Biofinity Multifocal D +2.50 add	Biofinity Multifocal D +2.50 add	The Biofinity Multifocal "D" with a +2.50 add is a soft bifocal contact lens that has a strong reading power

Primary Outcome Measures

Name	Time	Method
Refractive Error Progression	3 years	Refractive error, as measured by cycloplegic autorefraction in both eyes, will be measured yearly to assess the difference in progression between the two soft bifocal treatment lenses (+1.50 D add and +2.50 D add) and the control group (soft spherical contact lenses).

Secondary Outcome Measures

Name	Time	Method
Ocular Shape Change and Eye Growth	3 years	The outcome of interest is the change in ocular shape and measured by the change in peripheral refractive error in the right eye. The change in peripheral refractive error will be compared among the two treatment groups and the control group to determine whether peripheral defocus changes the shape of the eye globally (across the whole eye) or locally (specific to the region of the eye affected by the defocus).
Association of Peripheral Defocus to Myopic Progression	3 years	Peripheral defocus will be measured in 10 areas (Nasal and temporal zones at 20, 30, and 40 degrees, and superior and inferior zones at 20 and 30 degrees) and analyzed for its relation to myopia progression (as measured by cycloplegic autorefraction in the right eye only).
Axial Length Progression	3 years	Axial length progression, as measured by Lenstar in both eyes, will be measured yearly to assess the difference in progression between the two soft bifocal treatment lenses (+1.50 D add and +2.50 D add) and the control group (soft spherical contact lenses).

Trial Locations

Locations (2): Ohio State University College of Optometry
🇺🇸
Columbus, Ohio, United States
University of Houston College of Optometry
🇺🇸
Houston, Texas, United States
Ohio State University College of Optometry
🇺🇸Columbus, Ohio, United States